http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6770272-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7aa001f3235c07b0298867908d45e21
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-75
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-24
filingDate 2002-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34e75aafcc22d4628f187607ecc662e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdf9e29ae1adfd87499fd4dd69ca50ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a23c44784c6cf8a4f0e6c2c269c0a72b
publicationDate 2004-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6770272-B2
titleOfInvention Treatment of diabetes
abstract Disclosed are chimeric proteins having IL-10 fused to an enzymatically inactive polypeptide which increases the circulating half-life of IL-10. The chimeric polypeptides are useful for treating or preventing septic shock, inhibiting the development of Type I diabetes, and treating multiple myeloma in a patient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011091419-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10653751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010203677-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471126-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10350270-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10398761-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9238079-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10639353-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9823255-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2289500-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9364517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9833514-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925245-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8865652-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10618970-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413332-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10293043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10209261-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9943568-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10143726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195274-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357545-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568968-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10010588-B2
priorityDate 1994-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9212725-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5196321-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5231012-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5116964-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8807089-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9007932-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5447851-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9404180-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5428130-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5447851-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395503

Total number of triples: 74.